Fortress Biotech, Inc. Cash And Cash Equivalents At Carrying Value

• Fortress Biotech, Inc. showed an increase of +38.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2006 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2006: $0.00 | Q3 2010: $15.78 million | Q1 2011: $9.27 million | Q2 2011: $29.65 million | Q3 2011: $26.71 million | Q1 2012: $17.74 million | Q2 2012: $38.21 million | Q3 2012: $47.48 million | Q1 2013: $44.05 million | Q2 2013: $67.89 million | Q3 2013: $106.27 million | Q1 2014: $79.98 million | Q2 2014: $75.80 million | Q3 2014: $71.59 million | Q1 2015: $48.93 million | Q2 2015: $41.04 million | Q3 2015: $25.56 million | Q1 2016: $81.42 million | Q2 2016: $71.34 million | Q3 2016: $82.54 million | Q4 2016: $105.18 million | Q1 2017: $150.93 million | Q2 2017: $144.34 million | Q3 2017: $110.54 million | Q1 2018: $124.02 million | Q2 2018: $98.59 million | Q3 2018: $95.87 million | Q1 2019: $116.44 million | Q2 2019: $149.41 million | Q3 2019: $134.95 million | Q1 2020: $135.94 million | Q2 2020: $183.28 million | Q3 2020: $218.39 million | Q1 2021: $289.90 million | Q2 2021: $274.99 million | Q3 2021: $252.72 million | Q1 2022: $287.51 million | Q2 2022: $248.77 million | Q3 2022: $208.35 million | Q1 2023: $152.48 million | Q2 2023: $78.02 million | Q3 2023: $72.31 million | Q1 2024: $83.77 million | Q2 2024: $76.20 million | Q3 2024: $58.85 million | Q1 2025: $91.34 million | Q2 2025: $74.39 million | Q3 2025: $86.22 million.
• Historical annual values: Fiscal year 2025: $79.38 million | Fiscal year 2024: $57.26 million | Fiscal year 2023: $80.93 million | Fiscal year 2022: $178.27 million | Fiscal year 2021: $305.74 million | Fiscal year 2020: $233.35 million | Fiscal year 2019: $136.86 million | Fiscal year 2018: $65.51 million | Fiscal year 2017: $94.95 million | Fiscal year 2016: $88.29 million | Fiscal year 2015: $98.18 million | Fiscal year 2014: $49.76 million | Fiscal year 2013: $99.52 million | Fiscal year 2012: $40.20 million | Fiscal year 2011: $23.16 million | Fiscal year 2010: $14.86 million | Fiscal year 2009: $1.51 million | Fiscal year 2008: $7.0 thousand | Fiscal year 2006: $0.00.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026